New WHO guidelines recommend the phasing-out of the major HIV-drug Stavudine
November 29, 2009 – The World Health Organization (WHO) recently announced new recommendations (guidelines) on HIV-therapies worldwide. An important part of this announcement concerns Stavudine. Countries should phase out the use of Stavudine, the most widespread antiretroviral, because of “long-term, …
New WHO guidelines recommend the phasing-out of the major HIV-drug Stavudine Read more »